These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476 [TBL] [Abstract][Full Text] [Related]
10. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon. Whitmore SE; Wigley FM; Wise RA J Rheumatol; 1995 Jan; 22(1):50-4. PubMed ID: 7699682 [TBL] [Abstract][Full Text] [Related]
11. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon. Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542 [TBL] [Abstract][Full Text] [Related]
12. Sustained-release transdermal glyceryl trinitrate patches as a treatment for primary and secondary Raynaud's phenomenon. Teh LS; Manning J; Moore T; Tully MP; O'Reilly D; Jayson MI Br J Rheumatol; 1995 Jul; 34(7):636-41. PubMed ID: 7670782 [TBL] [Abstract][Full Text] [Related]
13. Infrared thermography in the diagnosis of Raynaud's phenomenon in vibration-induced white finger. von Bierbrauer A; Schilk I; Lucke C; Schmidt JA Vasa; 1998 May; 27(2):94-9. PubMed ID: 9612113 [TBL] [Abstract][Full Text] [Related]
14. A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon. Kahan A; Amor B; Menkes CJ Ann Rheum Dis; 1985 Jan; 44(1):30-3. PubMed ID: 3882061 [TBL] [Abstract][Full Text] [Related]
15. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon. Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193 [TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled study of prazosin in Raynaud's phenomenon. Wollersheim H; Thien T; Fennis J; van Elteren P; van 't Laar A Clin Pharmacol Ther; 1986 Aug; 40(2):219-25. PubMed ID: 3731684 [TBL] [Abstract][Full Text] [Related]
17. Isosorbide dinitrate ointment in Raynaud's disease. Diehm C; Müller-Bühl U; Mörl H Z Kardiol; 1983; 72 Suppl 3():185-7. PubMed ID: 6364591 [TBL] [Abstract][Full Text] [Related]
18. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker. Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603 [TBL] [Abstract][Full Text] [Related]
19. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon. Rhedda A; McCans J; Willan AR; Ford PM J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157 [TBL] [Abstract][Full Text] [Related]
20. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study. Arneklo-Nobin B; Elmér O; Akesson A Int Angiol; 1988; 7(1):19-25. PubMed ID: 3290356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]